Salvage surgery after definitive chemoradiotherapy for patients with non-small cell lung cancer

Definitive chemoradiotherapy (CRT) has been a standard of care for patients with unresectable stage III non-small cell lung cancer (NSCLC). However, locoregional recurrence occurs in about 30% of patients after definitive CRT. Recently, the addition of durvalumab as maintenance therapy has shown to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamada, Akira, Soh, Junichi, Mitsudomi, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Articles on Multimodal Management of Locally Advanced N2 Non-small Cell Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867739/
https://www.ncbi.nlm.nih.gov/pubmed/33569336
http://dx.doi.org/10.21037/tlcr-20-453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867739/
https://www.ncbi.nlm.nih.gov/pubmed/33569336
http://dx.doi.org/10.21037/tlcr-20-453

Ejemplares similares